New care pathway aims to ease cancer Patients' distress

NCT ID NCT06479057

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new way to provide supportive care for cancer patients. It will enroll 700 adults with any type of cancer. The care pathway includes a full needs assessment and referrals to support services. Researchers will measure whether this approach reduces patient distress and unmet needs after 12 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANY CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Gustave Roussy

    RECRUITING

    Villejuif, 94800, France

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could show that a structured supportive care pathway reduces distress and unmet needs for cancer patients, leading to better quality of life.

What could go wrong

This is an observational study, not a treatment trial. It measures outcomes without a control group, so any improvements may not be due to the pathway alone.

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.